Search alternatives:
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
3961
Tau phosphorylation is decreased in neurons treated with 20 mM KCl.
Published 2017“…The phosphorylation of S199/S202, T181, T205 and S404 was not significantly affected by 10mM of KCl treatment whereas the phosphorylation of all these sites was decreased by 20mM of KCl treatment. The signal of the phospho-antibodies was normalized to that of total Tau (n = 5, mean ± SEM, unpaired t-test two-tailed, *<i>P</i> < 0.05, ***<i>P</i> < 0.001). …”
-
3962
-
3963
-
3964
-
3965
-
3966
-
3967
-
3968
Twenty-two identified and replicated loci and their overlap with associations to metabolic traits and clinical phenotypes.
Published 2015“…<p><sup>a</sup> SNP with the strongest association to targeted metabolic traits (“lead SNP”)</p><p><sup>b</sup> SNP with the strongest association to non-targeted metabolic traits</p><p><sup>c</sup> manually added to the list of most plausible candidate genes derived by evidence-based selection</p><p><sup>d</sup> additional candidates match to other non-targeted traits that also associate with the lead SNP</p><p><sup>e</sup> results from GWAS (<i>P</i> < 5.0×10<sup>−8</sup>)</p><p><sup>f</sup> mutations determined in clinical studies</p><p>For each locus, we selected all variants that displayed genome-wide significant association signals to metabolic traits in the SHIP-0 cohort. …”
-
3969
-
3970
-
3971
-
3972
-
3973
GSK343 decreased viability and proliferation in human neuroblastoma PDX cells.
Published 2021“…GSK343 treatment resulted in significantly decreased viability. (B) COA3 and COA6 (1.5 × 10<sup>3</sup>) cells were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and proliferation was measured using CellTiter<sup>®</sup> assay. …”
-
3974
-
3975
-
3976
-
3977
-
3978
-
3979
-
3980